Pulse Biosciences, Inc (PLSE): Price and Financial Metrics


Pulse Biosciences, Inc (PLSE): $22.15

-0.34 (-1.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PLSE Stock Price Chart Interactive Chart >

Price chart for PLSE

PLSE Price/Volume Stats

Current price $22.15 52-week high $45.82
Prev. close $22.49 52-week low $11.40
Day low $21.98 Volume 16,543
Day high $22.64 Avg. volume 109,862
50-day MA $22.25 Dividend yield N/A
200-day MA $23.27 Market Cap 655.77M

Pulse Biosciences, Inc (PLSE) Company Bio


Pulse Biosciences, a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was founded in 2014 and is based in Burlingame, California.


PLSE Latest News Stream


Event/Time News Detail
Loading, please wait...

PLSE Latest Social Stream


Loading social stream, please wait...

View Full PLSE Social Stream

Latest PLSE News From Around the Web

Below are the latest news stories about Pulse Biosciences Inc that investors may wish to consider to help them evaluate PLSE as an investment opportunity.

Irreversible Electroporation Ablators Market2021: Business Opportunities, Current Trends, Market Challenges By 2027 | AngioDynamics, Pulse Biosciences

Irreversible Electroporation Ablators Market: Analyst View From 2021-2027 The Global Irreversible Electroporation Ablators Market work provides a concrete market definition along with a detailed structure of industry which helps readers gain a holistic understanding of the research. The study also includes

OpenPR | September 2, 2021

Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX® System powered by Nano-Pulse Stimulation (NPS) technology, today announced plans to participate in the upcoming virtual H.C. Wainwright Global Investment Conference. Management is scheduled to participate and hold one-on-one meetings Tuesday, September 14, 2021. A presentation webcast will be available at the start of the conference on Monday, September 13, 20

Business Wire | September 2, 2021

Is Pulse Biosciences (NASDAQ:PLSE) Weighed On By Its Debt Load?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Yahoo | September 2, 2021

Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation (NPS) technology, today announced the appointment of Mitchell E. Levinson to the newly created role of Chief Strategy Officer, effective immediately, in addition to the continuation of his role as a member of the Pulse Biosciences Board of Directors. As a Board member and medical device industry veteran with a trac

Business Wire | August 19, 2021

Pulse Biosciences Reports Second Quarter 2021 Financial Results

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation (NPS) technology, today announced financial results for the second quarter of 2021. Recent Highlights CellFX System Controlled Launch Program participants totaled 49 at the end of the second quarter, including 34 onboarded during the second quarter across the U.S., Europe and Canada, on track to complete program onb

Business Wire | August 9, 2021

Read More 'PLSE' Stories Here

PLSE Price Returns

1-mo -12.83%
3-mo 35.06%
6-mo -6.30%
1-year 88.99%
3-year 56.10%
5-year 251.03%
YTD -7.17%
2020 77.93%
2019 17.02%
2018 -51.44%
2017 263.08%
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0503 seconds.